Skip to main content

What the FDA labels say about taking them together

Cyclosporine and paltusotine

Paltusotine's FDA label of September 16, 2025 names cyclosporine in its drug interactions section; the cyclosporine labels PlainMeds reads (4) do not name paltusotine. The paltusotine label: “May require PALSONIFY dosage increase Cyclosporine: may decrease cyclosporine exposure.”

Check it at the source: the cyclosporine FDA label on DailyMed (effective August 10, 2026, Novartis Pharmaceuticals Corporation); the paltusotine FDA label on DailyMed (effective September 16, 2025, Crinetics Pharmaceuticals, Inc.).

What does the cyclosporine label say about paltusotine?

Cyclosporine's label (effective August 10, 2026) and its 3 other brand-application labels do not name paltusotine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Neoral), Novartis Pharmaceuticals Corporation, effective August 10, 2026 (SPL set 94461af3-11f1-4670-95d4-2965b9538ae3), via openFDA; the full label on DailyMed

What does the paltusotine label say about cyclosporine?

Paltusotine label, drug interactions

May require PALSONIFY dosage increase ( 2.3 , 7.1 ) Cyclosporine: may decrease cyclosporine exposure.

Source: FDA drug label (PALSONIFY), Crinetics Pharmaceuticals, Inc., effective September 16, 2025 (SPL set 8a6d2ce0-a621-4ee7-983c-977cd948ff4d), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

14Cyclosporine generic labelers
0Paltusotine generic labelers
CyclosporinePaltusotine
Labeled forOrgan transplant rejection, Rheumatoid arthritisn/a
Boxed warningYesNo
Pharmacy cost (NADAC)$1.04 per unit 0.05% eye emulsionn/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?